Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 100c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $83.99 +4.41%
Revenue Growth %: +89.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: +89.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($1.39), $1.00 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $74.42 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Bulldog Investors urges no vote on XFLT sub-advisor proposal
- Trump dodges divulging if U.S. will take a 5% stake in OpenAI - CNBC Interview
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
